1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients
Publication
, Conference
Saltos, A; Zheng, H; Arrowood, C; Beasley, G; Ronald, J; El-Haddad, G; Khan, U; Guerra-Guevara, L; Wolf, S; Gu, L; Wang, X; Cantwell, M ...
Published in: Regular and Young Investigator Award Abstracts
November 2022
Duke Scholars
Published In
Regular and Young Investigator Award Abstracts
DOI
Publication Date
November 2022
Start / End Page
A1176 / A1176
Publisher
BMJ Publishing Group Ltd
Conference Name
SITC 37th Annual Meeting (SITC 2022) Abstracts
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Saltos, A., Zheng, H., Arrowood, C., Beasley, G., Ronald, J., El-Haddad, G., … Ready, N. (2022). 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. In Regular and Young Investigator Award Abstracts (pp. A1176–A1176). BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2022-sitc2022.1132
Saltos, Andreas, Hong Zheng, Christy Arrowood, Georgia Beasley, James Ronald, Ghassan El-Haddad, Uzma Khan, et al. “1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients.” In Regular and Young Investigator Award Abstracts, A1176–A1176. BMJ Publishing Group Ltd, 2022. https://doi.org/10.1136/jitc-2022-sitc2022.1132.
Saltos A, Zheng H, Arrowood C, Beasley G, Ronald J, El-Haddad G, et al. 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. In: Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2022. p. A1176–A1176.
Saltos, Andreas, et al. “1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2022, pp. A1176–A1176. Crossref, doi:10.1136/jitc-2022-sitc2022.1132.
Saltos A, Zheng H, Arrowood C, Beasley G, Ronald J, El-Haddad G, Khan U, Guerra-Guevara L, Wolf S, Gu L, Wang X, Cantwell M, Antonia S, Beg A, Ready N. 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2022. p. A1176–A1176.
Published In
Regular and Young Investigator Award Abstracts
DOI
Publication Date
November 2022
Start / End Page
A1176 / A1176
Publisher
BMJ Publishing Group Ltd
Conference Name
SITC 37th Annual Meeting (SITC 2022) Abstracts
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology